Janux Therapeutics, Inc.

Q3 2025 13F Holders

Symbol
JANX
CUSIP
47103J105
Type
Equity
Class
COM
Num filings
186
Total reported value, excl. options
$1.60 B
Manager Report Date Value ($000) Shares Option Type